                         SEQUENCE LISTING

<110>  The General Hospital Corporation
       Myre, Michael
       Wasco, Wilma
       Tanzi, Rudolph E
 
<120>  REDUCTION OF BETA-AMYLOID LEVELS BY TREATMENT WITH THE SMALL 
       MOLECULE DIFFERENTIATION-INDUCING FACTOR

<130>  M0765.70093WO

<150>  US 60/959,646
<151>  2007-07-16

<160>  12    

<170>  PatentIn version 3.3

<210>  1
<211>  27
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
gacgccgctg tcgccccaga ggagcgc                                         27


<210>  2
<211>  27
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
gcgctcctct ggggcgacag cggcgtc                                         27


<210>  3
<211>  33
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  3
gttgacgccg ctgtcgaacc agaggagcgc cac                                  33


<210>  4
<211>  33
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  4
gtggcgctcc tctggttcga cagcggcgtc aac                                  33


<210>  5
<211>  18
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  5
atctccagcc gtggcatt                                                   18


<210>  6
<211>  18
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  6
ttcgtagccg ttctgctg                                                   18


<210>  7
<211>  47
<212>  PRT
<213>  homo sapiens

<400>  7

Lys Lys Lys Gln Tyr Thr Ser Ile His His Gly Val Val Glu Val Asp 
1               5                   10                  15      


Ala Ala Val Thr Pro Glu Glu Arg His Leu Ser Lys Met Gln Gln Asn 
            20                  25                  30          


Gly Tyr Glu Asn Pro Thr Tyr Lys Phe Phe Glu Gln Met Gln Asn 
        35                  40                  45          


<210>  8
<211>  47
<212>  PRT
<213>  homo sapiens

<400>  8

Arg Lys Arg Gln Tyr Gly Thr Ile Ser His Gly Ile Val Glu Val Asp 
1               5                   10                  15      


Pro Met Leu Thr Pro Glu Glu Arg His Leu Asn Lys Met Gln Asn His 
            20                  25                  30          


Gly Tyr Glu Asn Pro Thr Tyr Lys Tyr Leu Glu Gln Met Gln Ile 
        35                  40                  45          


<210>  9
<211>  47
<212>  PRT
<213>  homo sapiens

<400>  9

Arg Arg Lys Lys Pro Tyr Gly Ala Ile Ser His Gly Val Val Glu Val 
1               5                   10                  15      


Asp Pro Met Leu Thr Leu Glu Glu Gln Gln Leu Arg Glu Leu Gln Arg 
            20                  25                  30          


His Gly Tyr Glu Asn Pro Thr Tyr Arg Phe Leu Glu Glu Arg Pro 
        35                  40                  45          


<210>  10
<211>  6
<212>  PRT
<213>  homo sapiens

<400>  10

Tyr Glu Asn Pro Thr Tyr 
1               5       


<210>  11
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  wherein X is any amino acid residue

<400>  11

Asn Pro Xaa Tyr 
1               


<210>  12
<211>  7
<212>  PRT
<213>  homo sapiens

<400>  12

Gly Tyr Glu Asn Pro Thr Tyr 
1               5           


